New findings indicate that Abbott‘s FreeStyle Libre® continuous glucose monitoring (CGM) technology is linked to a significant reduction in hospitalizations for heart complications among people with diabetes. The results highlight the beneficial effect of this biowearable tech over conventional blood glucose monitoring.
As reported, those with Type 1 diabetes who had a history of having severe low blood sugar events experienced a stunning 78% decrease in hospitalization due to cardiovascular disease when they used the FreeStyle Libre system.
These results are remarkable, as we see dual benefits from CGM technology in managing diabetes and its associated cardiovascular complications,
CGMs empower people to proactively manage their diabetes and make informed health choices through real-time, constant feedback on their glucose levels. This data shows that using CGMs is linked with significantly reduced hospitalizations related to heart issues, which can have a significant impact on patients, their families and the healthcare system by easing medical, emotional and financial burdens.
David Nathanson
In addition, the research showed an 80% reduction in the hospitalization risk of cardiovascular disease in individuals with Type 1 diabetes who did not have a previous history of such illnesses. In individuals with a previous history of cardiovascular disease, there was a reduction by 49% in the risk of hospitalization when the Libre technology was used.
These key results are from the REFLECT studies, which were actual-world retrospective analyses supported by Abbott. The study used data from the Swedish National Diabetes Register (NDR), a large database that covers about 90% of all diabetes patients in Sweden.
Abbott’s FreeStyle Libre CGM technology has revolutionized the treatment of diabetes ever since it was launched 10 years ago. Today, it is used by more than 7 million individuals in more than 60 countries around the globe. The new data further highlights the advantages of the technology in enhancing the health outcomes of individuals with diabetes by considerably reducing the risk of severe cardiac-related complications.
Last Modified:
Graduated from the University of Kerala with B.Sc. Botany and Biotechnology. Attained Post-Graduation in Biotechnology from the Kerala University of Fisheries and Ocean Science (KUFOS) with the third rank. Conducted various seminars and attended major Science conferences. Done 6 months of internship in ICMR – National Institute of Nutrition, Hyderabad. 5 years of tutoring experience.
